DC Circ. Ruling Dangerous For Hatch-Waxman: Takeda
Takeda Pharmaceuticals USA Inc. and hedge funds that invested in it asked the D.C. Circuit Monday to reconsider its dismissal of their suit alleging the Food and Drug Administration violated patent...To view the full article, register now.
Already a subscriber? Click here to view full article